The eGFP LNCaP stable cell line is engineered to constitutively express enhanced green fluorescent protein (eGFP), providing a reliable, fluorescence-based model for prostate cancer research and assay development. Stable eGFP expression enables real-time visualization and quantitative analysis without the need for repeated transfection.
Built on the androgen-sensitive LNCaP background, this cell line retains key features of prostate cancer biology, including androgen receptor (AR) signaling, making it well suited for studying tumor progression, hormone response, and therapeutic intervention. The uniform and stable eGFP signal ensures consistent performance across experiments, improving reproducibility and assay sensitivity.
Key Features
Stable, high-level eGFP expression
Eliminates the need for transient transfection
Suitable for live-cell imaging and flow cytometry
Compatible with high-throughput screening applications
Applications
Monitoring transduction or gene editing efficiency
Cell tracking and imaging studies
Drug screening and cytotoxicity assays
Prostate cancer and androgen signaling research